Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec (Q33990521)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

0 references

Clostridium difficile

0 references

1 reference

based on heuristic

inferred from title

author name string

Jacques Pépin

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nathalie Saheb

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marie-Andrée Coulombe

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marie-Eve Alary

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marie-Pier Corriveau

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Simon Authier

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Michel Leblanc

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Geneviève Rivard

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mathieu Bettez

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Valérie Primeau

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Martin Nguyen

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Claude-Emilie Jacob

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Luc Lanthier

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

20 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1254-1260

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

C. difficile: by the numbers

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Clinical practice. Antibiotic-associated diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Risk factors for Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Epidemiology, risk factors and treatments for antibiotic-associated diarrhea.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Risk factors for Clostridium difficile toxin-associated diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Epidemiology of Clostridium difficile-associated infections

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Immunosenescence and infectious diseases

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Antibiotic-associated diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Antibiotics and Clostridium difficile

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Clostridium difficile in long-term-care facilities for the elderly

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Fluoroquinolone prescribing in the United States: 1995 to 2002.

1 reference

https://api.crossref.org/works/10.1086%2F496986

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

release_d4pnj6dizvdbpgrljisheslrj4

1 reference

https://api.fatcat.wiki/v0/release/d4pnj6dizvdbpgrljisheslrj4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33990521&oldid=1989026198"